KKR to sell minority stake in Nordic Bioscience to company founder
Thursday, September 3, 2026 · first reported by PE Hub
KKR divests minority stake in Nordic Bioscience to company founder; investment doubled company revenue across R&D, diagnostics, and drug development.
- Firm
- KKR
- Also named
- Nordic Bioscience
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on KKR
Everything on this firm →More in Deals
From the same day- Thoma Bravo-backed Proofpoint in talks to acquire VaronisPrivate Equity Wire
- Carlyle, Bain and Oaktree line up bids for Serie A international media businessPrivate Equity Wire
- TPG-backed Asia OneHealthcare confidentially files for potential $2.5bn Malaysia IPOPrivate Equity Wire
- Thoma Bravo weighs $2bn-plus sale of Foundation SoftwarePrivate Equity Wire
- EQT Completed Its Combination With Coller Capital as Coller EQTHedgeCo Insights
- Permira and CPP Investments Completed the £2.7 Billion Take-Private of JTCHedgeCo Insights